FiercePharmaAsia—Biocon, Mylan’s Lantus copy; Samsung rides COVID demand; Adlai Nortye’s C round aliu Fri, 09/04/2020 – 06:28

With new AveXis name, Novartis spotlights marquee role for gene therapy business bbulik Fri, 09/04/2020 – 09:19

A COVID-19 vaccine in early November? ‘Extremely unlikely, but not impossible’: Warp Speed head Slaoui esagonowsky Fri, 09/04/2020 […]

An increased awareness on a molecular level of what mechanisms prostate cancer cells use to become mobile and […]

The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, […]

Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill […]

The technique has been used to generate a high-affinity antibody against Arginase 2, an enzyme implicated in major […]

The findings have validated confidence in the experimental vaccine, the firm noted

The medicine is being assessed for treating adults hospitalised with the virus

Updated Date: Thu, 27 Aug 2020 00:00:00 EDT